Health

The CBD-Intel Health hub presents developments related to the science behind CBD and health.

Regulatory tracker: current global regulation of CBD October 2020

6th October 2020 - Regulatory trackers |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Pennsylvania
Peru
Philippines
Poland
Portugal
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zimbabwe
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Regulatory trackers

CBD-Intel’s newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.

Use the tabs at the top of the map to select a specific regulatory field and click on an individual country to bring up much more detail in the panel below, including links to legislation and CBD-Intel’s coverage of that market.

The key below the map indicates the level of regulation for the selected country and regulatory field based on our in-house analysis.

Topicals status across top CBD markets

1st October 2020 - Presentations , Resources |

World
Companies
Health
Market Research
Marketing and Retailing
Technology and Innovation
Presentations
Resources

Maria Alejandra Estanga, our market analysts, presented the current status of the topicals market across the most important CBD markets during the Virtual Cannacosmo Health + Beauty Expo on 29st September.

Podcast: what can European markets do with CBD Novel Food applications?

2nd September 2020 - Podcasts , Resources |

Europe
World
Companies
Food
Health
Market Research
Marketing and Retailing
Regulation and Legislation
Podcasts
Resources

CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.

Now that novel food applications in Europe are delayed, what does enforcement look like?

10th July 2020 - Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog

Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.

How is the novel food status of CBD progressing in Europe?

3rd July 2020 - Blog |

Europe
Companies
Food
Health
Policy and Politics
Regulation and Legislation
Blog

Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the  Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.

CBD-Intel COVID-19 news round-up

30th April 2020 - Business briefing |

Afghanistan
Africa
Alabama
Alaska
Albania
Algeria
Andorra
Argentina
Arizona
Arkansas
Armenia
Armenia
Asia
Australasia
Australia
Austria
Bahrain
Bangladesh
Belarus
Belgium
Bolivia
Bosnia and Herzegovina
Brazil
Bulgaria
California
Cambodia
Canada
Chile
China
Colombia
Colorado
Connecticut
Costa Rica
Croatia
Cyprus
Czech Republic
Delaware
Democratic Republic of the Congo
Denmark
Ecuador
Egypt
England
Estonia
Ethiopia
EU
Europe
Finland
Florida
France
Georgia
Georgia
Germany
Ghana
Greece
Hawaii
Honduras
Hong Kong
Hungary
Iceland
Idaho
Illinois
India
Indiana
Indonesia
Iowa
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Japan
Kansas
Kazakhstan
Kentucky
Kenya
Kosovo
Kuwait
Kyrgyzstan
Latvia
Lebanon
Lesotho
Libya
Lithuania
Louisiana
Luxemburg
Macedonia
Maine
Malawi
Malaysia
Malta
Maryland
Massachusetts
Mauritania
Mexico
Michigan
Middle East
Minnesota
Mississippi
Missouri
Moldova
Monaco
Montana
Montenegro
Morocco
Mozambique
Myanmar
Namibia
Nebraska
Nepal
Netherlands
Nevada
New Hampshire
New Jersey
New Mexico
New York
New Zealand
Nigeria
North America
North Carolina
North Dakota
North Korea
Northern Ireland
Norway
Ohio
Oklahoma
Oman
Oregon
Pakistan
Panama
Paraguay
Pennsylvania
Peru
Philippines
Poland
Portugal
Puerto Rico
Qatar
Rhode Island
Romania
Russia
San Marino
Saudi Arabia
Scandinavia
Scotland
Serbia
Singapore
Slovakia
Slovenia
South Africa
South America
South Carolina
South Dakota
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Tennessee
Texas
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Utah
Uzbekistan
Vatican City
Venezuela
Vermont
Vietnam
Virginia
Wales
Washington
Washington D.C.
West Virginia
Wisconsin
World
Wyoming
Yemen
Zambia
Zimbabwe
Health
Marketing and Retailing
Policy and Politics
Regulation and Legislation
Science
Business briefing

In order to help you keep track of how all this is affecting the CBD industry around the world, all CBD-Intel’s COVID-19-related coverage can now be found in one place here

Denver-to-Dallas move goes ahead despite coronavirus outbreak

25th March 2020 - Business briefing |

Australasia
Australia
Colorado
EU
Europe
Kentucky
North America
Texas
United States
Vermont
Companies
COVID-19
Farming
Health
Science
Business briefing

Also: GW suggests another possible use for Epidyolex; Lawsuit alleges hemp plants were contaminated with pesticide; Elixinol rebrands to move away from medicinal image; Kentucky hemp business goes bust

CBD events called off or put back as coronavirus tightens grip

19th March 2020 - Business briefing |

California
Europe
Georgia
Germany
Illinois
Italy
North America
Spain
United Kingdom
United States
Companies
COVID-19
Health
Business briefing

As the COVID-19 pandemic continues to affect people across the world, a swathe of CBD-related events have been called off or postponed. Here is a list of some of the major ones, with dates and details

Toothpaste giant enters CBD market: business news in brief

26th February 2020 - Business briefing |

Arizona
Asia
Australasia
Australia
California
Canada
Colorado
Europe
Florida
Germany
Israel
Louisiana
Netherlands
Nevada
North America
Pennsylvania
Switzerland
Texas
United States
Washington
Companies
Farming
Health
Technology and Innovation
Business briefing

Toothpaste giant Colgate is entering the CBD market, researchers have created a laser scanner that can tell the difference between legal hemp and potentially illegal cannabis, and wrestling legend Kevin Nash has become the latest celebrity to endorse CBD, plus more

BfR issues warning over adulterated German e-liquids

21st February 2020 - Regulatory briefing |

Europe
Germany
Health
Policy and Politics
Regulation and Legislation
Regulatory briefing

Germany’s Federal Institute for Risk Assessment (BfR) recently issued a warning on e-liquids that it believed to be containing synthetic cannabinoids, after at least eight teenagers suffered medical complications from an as yet unconfirmed source

Actor refutes claims he endorsed CBD products: business news in brief

18th February 2020 - Business briefing |

Asia
Australasia
Australia
Belgium
Brazil
California
Canada
Colorado
Delaware
Europe
Israel
Nevada
New York
North America
South America
Texas
United States
Vermont
Virginia
Wyoming
Companies
Health
Technology and Innovation
Business briefing

Tom Hanks refutes false claims over endorsement of CBD products, research suggests cannabinoids benefit gene receptor diseases and CBD coffee is set to hit the market, plus more

Video: Brexit round table

7th December 2019 - Resources , Videos |

Europe
United Kingdom
Health
Policy and Politics
Regulation and Legislation
Resources
Videos

The organisers of Hemp and CBD Expo invited our MD, Tim Phillips, to participate in their round table about Brexit. Their aim was to objectively understand what the Brexit impacts are going to be over the next few years for CBD and the UK CBD industry. Don’t miss out on this interesting debate. If you […]